The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice

Laura A Magee; Mark A Brown; David R Hall; Sanjay Gupte; Annemarie Hennessy; S Ananth Karumanchi; Louise C Kenny; Fergus McCarthy; Jenny Myers; Liona C Poon; Sarosh Rana; Shigeru Saito; Anne Cathrine Staff; Eleni Tsigas; Peter von Dadelszen

doi:10.1016/j.preghy.2021.09.008

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice

Pregnancy Hypertens. 2022 Mar:27:148-169. doi: 10.1016/j.preghy.2021.09.008. Epub 2021 Oct 9.

Authors

Affiliations

¹ Department of Women and Children's Health, School of Life Course Sciences, King's College London, UK. Electronic address: laura.a.magee@kcl.ac.uk.
² Departments of Renal Medicine & Medicine, St. George Hospital & University of New South Wales, Sydney, Australia.
³ Department of Obstetrics & Gynaecology, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
⁴ Secretary General, World Organization Gestosis, Gupte Hospital, Pune, India.
⁵ School of Medicine, Western Sydney University and South Western Sydney Local Health District, Sydney, Australia.
⁶ Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
⁷ Faculty of Health & Life Sciences, University of Liverpool and INFANT Centre, Cork University Maternity Hospital, Cork, Ireland.
⁸ Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland.
⁹ Maternal & Fetal Health Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
¹⁰ Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Chair of Hypertension in Pregnancy Subcommittee FIGO Pregnancy and NCD Committee, Hong Kong.
¹¹ Department of Obstetrics and Gynecology/Division of Maternal Fetal Medicine, University of Chicago, Chicago, IL, USA.
¹² Department of Obstetrics and Gynecology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Japan.
¹³ Faculty of Medicine, University of Oslo, and Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway; Global Pregnancy Collaboration (Member, Steering and Executive Committees), USA.
¹⁴ Preeclampsia Foundation, USA.
¹⁵ Department of Women and Children's Health, School of Life Course Sciences, King's College London, UK.

PMID: 35066406
DOI: 10.1016/j.preghy.2021.09.008

Abstract

All units managing hypertensive pregnant women should maintain and review uniform departmental management protocols and conduct regular audits of maternal & fetal outcomes. The cause(s) of pre-eclampsia and the optimal clinical management of the hypertensive disorders of pregnancy remain uncertain; therefore, we recommend that every hypertensive pregnant woman be offered an opportunity to participate in research, clinical trials and follow-up studies.

Keywords: Hypertension; Maternal; Outcome; Perinatal; Pre-eclampsia; Pregnancy.

Publication types

Practice Guideline

MeSH terms

Antihypertensive Agents / therapeutic use*
Blood Pressure Determination / methods*
Exercise
Female
Humans
Postnatal Care / methods
Pre-Eclampsia / diagnosis*
Pre-Eclampsia / drug therapy*
Pre-Eclampsia / prevention & control
Pregnancy
Proteinuria / urine
Risk Factors
Societies, Medical

Substances

Antihypertensive Agents